These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1869975)

  • 1. False-negative dipyridamole-thallium-201 myocardial imaging after caffeine infusion.
    Smits P; Corstens FH; Aengevaeren WR; Wackers FJ; Thien T
    J Nucl Med; 1991 Aug; 32(8):1538-41. PubMed ID: 1869975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caffeine reduces dipyridamole-induced myocardial ischemia.
    Smits P; Aengevaeren WR; Corstens FH; Thien T
    J Nucl Med; 1989 Oct; 30(10):1723-6. PubMed ID: 2795213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xanthine interference with dipyridamole-thallium-201 myocardial imaging.
    Stanek EJ; Melko GP; Charland SL
    Ann Pharmacother; 1995 Apr; 29(4):425-7. PubMed ID: 7633022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum caffeine levels after 24-hour abstention: clinical implications on dipyridamole (201)Tl myocardial perfusion imaging.
    Zheng XM; Williams RC
    J Nucl Med Technol; 2002 Sep; 30(3):123-7. PubMed ID: 12186961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inadequate exercise leads to suboptimal imaging. Thallium-201 myocardial perfusion imaging after dipyridamole combined with low-level exercise unmasks ischemia in symptomatic patients with non-diagnostic thallium-201 scans who exercise submaximally.
    Verzijlbergen JF; Vermeersch PH; Laarman GJ; Ascoop CA
    J Nucl Med; 1991 Nov; 32(11):2071-8. PubMed ID: 1941141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thallium-201 myocardial imaging in patients with coronary artery disease: comparison of intravenous adenosine and oral dipyridamole.
    Mohiuddin SM; Gupta NC; Esterbrooks DJ; Siffring PA; Frick MP; Hilleman DE; Sketch MH
    Ann Pharmacother; 1992 Nov; 26(11):1352-7. PubMed ID: 1477436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of caffeine on myocardial blood flow at rest and during pharmacological vasodilation.
    Böttcher M; Czernin J; Sun KT; Phelps ME; Schelbert HR
    J Nucl Med; 1995 Nov; 36(11):2016-21. PubMed ID: 7472591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum caffeine levels after 24 hours of caffeine abstention: observations on clinical patients undergoing myocardial perfusion imaging with dipyridamole or adenosine.
    Jacobson AF; Cerqueira MD; Raisys V; Shattuc S
    Eur J Nucl Med; 1994 Jan; 21(1):23-6. PubMed ID: 8088282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thallium-201-dipyridamole imaging: comparison between a standard dose and a high dose of dipyridamole in the detection of coronary artery disease.
    Lalonde D; Taillefer R; Lambert R; Bisson G; Basile F; Prieto I; Benjamin C
    J Nucl Med; 1994 Aug; 35(8):1245-53. PubMed ID: 8046475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of dipyridamole thallium imaging in a patient with myocardial bridging but without fixed obstructive coronary artery disease.
    Rivitz SM; Yasuda T
    J Nucl Med; 1992 Oct; 33(10):1905-13. PubMed ID: 1403164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective comparison of rubidium-82 PET and thallium-201 SPECT myocardial perfusion imaging utilizing a single dipyridamole stress in the diagnosis of coronary artery disease.
    Go RT; Marwick TH; MacIntyre WJ; Saha GB; Neumann DR; Underwood DA; Simpfendorfer CC
    J Nucl Med; 1990 Dec; 31(12):1899-905. PubMed ID: 2266384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the severity of coronary artery disease by thallium-201 washout rate after dipyridamole infusion--a coronary hemodynamic and metabolic study.
    Tamoto S; Ishihara T; Kojima S; Hosokawa H; Ohkubo T; Ohtuji S; Fukai M; Takada K; Seki I; Ohsawa N
    Jpn Circ J; 1995 Jan; 59(1):11-22. PubMed ID: 7752441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and clinical utility of combined intravenous dipyridamole/symptom-limited exercise stress test with thallium-201 imaging in patients with known or suspected coronary artery disease.
    Ignaszewski AP; McCormick LX; Heslip PG; McEwan AJ; Humen DP
    J Nucl Med; 1993 Dec; 34(12):2053-61. PubMed ID: 8254386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of adenosine triphosphate and dipyridamole in diagnosis by thallium-201 myocardial scintigraphy.
    Watanabe K; Sekiya M; Ikeda S; Miyagawa M; Kinoshita M; Kumano S
    J Nucl Med; 1997 Apr; 38(4):577-81. PubMed ID: 9098205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radionuclide methods of identifying patients who may require coronary artery bypass surgery.
    Beller GA; Gibson RS; Watson DD
    Circulation; 1985 Dec; 72(6 Pt 2):V9-22. PubMed ID: 3905063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of maintenance oral theophylline on dipyridamole-thallium-201 myocardial imaging using SPECT and dipyridamole-induced hemodynamic changes.
    Daley PJ; Mahn TH; Zielonka JS; Krubsack AJ; Akhtar R; Bamrah VS
    Am Heart J; 1988 Jun; 115(6):1185-92. PubMed ID: 3259827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial imaging with dipyridamole: comparison of the sensitivity and specificity of 201Tl versus MUGA.
    Harris D; Taylor D; Condon B; Ackery D; Conway N
    Eur J Nucl Med; 1982; 7(1):1-5. PubMed ID: 6460627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thallium-201 myocardial imaging during coronary vasodilation induced by oral dipyridamole.
    Gould KL; Sorenson SG; Albro P; Caldwell JH; Chaudhuri T; Hamilton GW
    J Nucl Med; 1986 Jan; 27(1):31-6. PubMed ID: 3941362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dipyridamole-induced ST segment depression during thallium-201 imaging in patients with coronary artery disease: angiographic and hemodynamic determinants.
    Chambers CE; Brown KA
    J Am Coll Cardiol; 1988 Jul; 12(1):37-41. PubMed ID: 3379218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of coronary artery disease using dipyridamole thallium-201 imaging.
    Chao CL; Lee YT; Chieng PU; Ho FM; Shiau YC; Shen SJ; Su CT; Huang PJ
    J Formos Med Assoc; 1994; 93(11-12):906-10. PubMed ID: 7633192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.